Latest Flerie News & Updates

See the latest news and media coverage for Flerie. We track all announcements, press releases, and industry mentions in real time, all in one place.

Flerie

Active long-term life science investor

flerie.com

Headquarters: Stockholm, Sweden
Founded year: 2011
Company type: Private company
Number of employees: 2–20
Industry: Investment Holding Companies

Last updated Today

Latest news about Flerie

In short: Flerie completed its merger with Lipum, progressed a merger plan with Biosergen, and reported a net asset value of SEK 3.4 billion.

Company announcements

September 11 Flerie

Flerie portfolio company Mendus announces positive trial read-out

The announcement follows a Data Safety Monitoring Board review of the first safety and tolerability stage of the VITAL-CML trial.

August 6 Flerie

Flerie shareholders approved the merger plan with Biosergen

The absorption merger exchanges 31 Biosergen shares for one new Flerie share, with the board authorized to issue shares as consideration, registered during Q4 2026.

July 16 Flerie

Flerie publishes merger document for Biosergen merger

The document outlines the merger plan where Biosergen is absorbed into Flerie, with EGMs on August 6, 2026.

July 9 Flerie

Flerie reports net asset value decrease in Q2 2026

Net profit was SEK -92 million, with portfolio fair value down 3.0% due to negative share price development in Xspray and Xintela.

Media coverage

Yesterday FinanzNachrichten.de

Biosergen AB: Biosergen applies for delisting of the company's shares from Nasdaq First North Growth Market conditional upon completion of the merger with Flerie

The Board of Directors of Biosergen AB ("Biosergen" or the "Company") has today, on 15 September 2026, in connection with the contemplated merger between Biosergen...

September 10 Investing.com

Should we buy, sell or hold FLERIE?

The consensus assessment for Flerie AB is "Strong Buy", based on insights from 1 analyst. 1 analyst recommends buying the stock, 0 suggest selling and 0...

August 31 BioStock

Biosergen comments on the oversubscribed rights issue - Biostock

Following an extensive evaluation, the board concluded on 26 June that a merger with Flerie was the best way forward. Flerie will acquire Biosergen through...

July 29 Yahoo Finance

Flerie AB N (1NP1.F) Q1 FY2026 earnings call transcript

Earnings call Flerie delivered a robust Q1 2026, raising SEK 208 million in new financing and achieving a 9% sequential increase in net asset value...

Never miss news about Flerie

Track Flerie and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Flerie competitors & trending companies

Browse news for competitors to Flerie and other trending companies.